Want to see IN:GPTHEALTH full AI Analyst Report?
GPTHEALTH Stock Chart & Stats
₹147.85
-₹0.33(-0.18%)
At close: 4:00 PM EST
₹147.85
-₹0.33(-0.18%)
Day’s Range― - ―
52-Week Range₹114.00 - ₹175.00
Previous CloseN/A
Volume58.95K
Average Volume (3M)8.89K
Market Cap
₹12.38B
Enterprise Value₹9.87K
Total Cash (Recent Filing)₹471.96M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)26.3
Beta0.84
Next Earnings
Nov 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.66%
Share Statistics
EPS (TTM)5.76
Shares Outstanding82,054,825
10 Day Avg. Volume9,309
30 Day Avg. Volume8,890
Financial Highlights & Ratios
PEG Ratio-1.46
Price to Book (P/B)3.50
Price to Sales (P/S)2.00
P/FCF Ratio23.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)7.7
Revenue Forecast (FY)₹5.58B
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthSustained revenue expansion, including a stronger FY2026 increase, indicates ongoing demand and business traction. Continued top-line growth can support operating scale, preserve investment capacity, and strengthen GPT Healthcare’s ability to build earnings over the next several quarters.
Improved Balance-Sheet LeverageThe substantial reduction in leverage has improved financial resilience and reduced balance-sheet pressure compared with earlier years. Moderate debt levels give the company greater flexibility to fund operations and growth while retaining an attractive FY2026 return on equity of about 15.7%.
Solid Operating Cash Flow And Gross MarginOperating cash flow that broadly matches or exceeds reported earnings supports the quality of the company’s profit generation. Combined with a healthy gross margin, this provides a sound base for funding operations, although cash conversion below that level remains an important consideration.
Bears Say
Profit And Margin CompressionThe deterioration in margins shows that revenue growth is not currently translating into stronger bottom-line earnings. If higher costs or investment pressure persist, weaker profitability could limit internal funding, reduce earnings quality, and temper the benefits of continued sales expansion.
Volatile Free-Cash-Flow ConversionUneven free-cash-flow conversion makes the company’s cash generation less predictable than its accounting earnings. Repeated volatility, including sharp declines in FY2024 and FY2025, may constrain reinvestment, debt reduction, or shareholder returns if capital spending or working-capital demands remain elevated.
Debt Increased In FY2026Although leverage remains moderate, the renewed increase in total debt signals that balance-sheet improvement has not been uninterrupted. Continued borrowing could raise financial obligations and reduce flexibility, particularly if margin pressure or inconsistent free-cash-flow generation persists.
GPT Healthcare Limited News
GPTHEALTH FAQ
What was GPT Healthcare Limited’s price range in the past 12 months?
GPT Healthcare Limited lowest stock price was ₹114.00 and its highest was ₹175.00 in the past 12 months.
What is GPT Healthcare Limited’s market cap?
GPT Healthcare Limited’s market cap is ₹12.38B.
When is GPT Healthcare Limited’s upcoming earnings report date?
GPT Healthcare Limited’s upcoming earnings report date is Nov 14, 2026 which is in 43 days.
How were GPT Healthcare Limited’s earnings last quarter?
GPT Healthcare Limited released its earnings results on Aug 03, 2026. The company reported ₹1.552 earnings per share for the quarter.
Is GPT Healthcare Limited overvalued?
According to Wall Street analysts GPT Healthcare Limited’s price is currently Overvalued.
Does GPT Healthcare Limited pay dividends?
GPT Healthcare Limited pays a Semiannually dividend of ₹1.5 which represents an annual dividend yield of 1.66%. See more information on GPT Healthcare Limited dividends here
What is GPT Healthcare Limited’s EPS estimate?
GPT Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GPT Healthcare Limited have?
GPT Healthcare Limited has 82,054,825 shares outstanding.
What happened to GPT Healthcare Limited’s price movement after its last earnings report?
GPT Healthcare Limited reported an EPS of ₹1.552 in its last earnings report. Following the earnings report the stock price went down -3.903%.
Which hedge fund is a major shareholder of GPT Healthcare Limited?
Currently, no hedge funds are holding shares in IN:GPTHEALTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
GPT Healthcare Limited
GPT Healthcare Limited runs a network of multispecialty hospitals across India under the ILS Hospitals brand. The company provides an extensive array of medical services, encompassing internal medicine, diabetology, and specialized nephrology procedures like renal transplants. Its offerings also include various laparoscopic and general surgeries, gynecology and obstetrics, critical care, gastroenterology, orthopedics with joint replacement, interventional cardiology, neurosciences, pediatrics, diagnostic facilities, and neonatology. Furthermore, the company manages its own pharmacies. Established in 1989, GPT Healthcare Limited is headquartered in Kolkata, India, and operates as a subsidiary of GPT Sons Pvt. Ltd.
Technical Analysis
Artemis Medicare Services Ltd.
―
Indraprastha Medical Corporation Limited
―
Shalby Ltd.
―
Suraksha Diagnostic Ltd.
―
Kovai Medical Center & Hospital Ltd.
―